🔥 Trending Thyroid Medication Recall: What You Need to Know

Nationwide Recall Issued for Levothyroxine Sodium Tablets

A nationwide recall has been issued for certain lots of levothyroxine sodium tablets, a widely used medication for treating hypothyroidism and reducing the size of enlarged thyroid glands ¹³⁴. The recall was initiated by Major Rugby, a pharmaceutical manufacturer, due to concerns that the tablets are "subpotent," meaning they may contain less active ingredient than required ³⁵⁸. This could lead to sub-therapeutic dosing for patients ².

Affected Medication and Manufacturer

The recall specifically involves levothyroxine sodium tablets. While multiple sources mention Major Rugby as the manufacturer initiating the recall ³, Major Pharmaceuticals has also been cited as the entity recalling 12 lots of the medication ⁶. It is crucial for patients to check their specific medication and lot numbers against official recall notices.

Reason for the Recall

The primary reason for the recall is the detection of subpotency in the tablets ¹⁵⁸. This means the medication may not deliver the intended dosage of the active ingredient, levothyroxine. For individuals with hypothyroidism, an underactive thyroid, receiving an insufficient dose can lead to uncontrolled symptoms and potential health complications ¹⁴. The FDA has upgraded this to a Class II alert, indicating that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote ²⁵.

What Patients Should Do

Patients currently taking levothyroxine sodium tablets are advised to:

• Check their medication: Verify if their specific medication, dosage, and lot number are included in the recall. Official recall notices, often found on the FDA website or through healthcare providers, will provide this detailed information ⁵⁶.
• Contact their healthcare provider: Patients should not stop taking their medication without consulting their doctor ⁷. Abruptly stopping thyroid medication can have adverse health effects. Their doctor can advise on next steps, such as obtaining a new prescription or an alternative medication ⁷.
• Monitor for symptoms: Patients should be aware of any changes in their thyroid condition or the re-emergence of hypothyroidism symptoms.

The recall was initiated on July 13, 2026, and affects multiple dosage strengths across the U.S. ⁸.